Caricamento...
Efficacy of a Once‐Daily Formulation of Carvedilol for the Treatment of Hypertension
β‐Blockers with pharmacologic effects that differ from conventional agents might add to antihypertensive treatment options. This study evaluated a new once‐daily formulation of the β‐/α(1)‐blocker, carvedilol controlled‐release (CR), in hypertensive patients off treatment or while still taking up to...
Salvato in:
| Pubblicato in: | J Clin Hypertens (Greenwich) |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Le Jacq Ltd.
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109495/ https://ncbi.nlm.nih.gov/pubmed/17170609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2006.05696.x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|